Drug Approval | July 10, 2024
Lupin receives tentative approval from USFDA for Empagliflozin, Linagliptin and Metformin Hydrochloride ER tablets
This product will be manufactured at Lupin’s Pithampur facility in India
This product will be manufactured at Lupin’s Pithampur facility in India
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Combined entity is better positioned to compete in increasingly competitive generics industry
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Lupin updates on shipment of Mirabegron ER Tablets
The product is used to treat amyotrophic lateral sclerosis
Subscribe To Our Newsletter & Stay Updated
